N-acetyltransferase activity in the urine in Japanese subjects: Comparison in healthy persons and bladder cancer patients

被引:16
作者
Ishizu, S
Hashida, C
Hanaoka, T
Maeda, K
Ohishi, Y
机构
[1] YOKOHAMA NATL UNIV,CTR HLTH,HODOGAYA KU,YOKOHAMA,KANAGAWA 240,JAPAN
[2] TOKYO WOMENS MED COLL,DEPT UROL,SHINJUKU KU,TOKYO 162,JAPAN
[3] TOKYO JIKEIKAI MED COLL,DEPT UROL,MINATO KU,TOKYO 105,JAPAN
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1995年 / 86卷 / 12期
关键词
N-acetyltransferase phenotype; Japanese healthy men; bladder cancer; AcINH/INH ratio;
D O I
10.1111/j.1349-7006.1995.tb03312.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The activity of urinary N-acetylamino-transferase was determined by high-performance liquid chromatographic assay of acetylisoniazid and isoniazid after administration of isoniazid to healthy Japanese male and bladder cancer patients in Japan, The healthy subjects were 47 college students and 44 company employees ranging from 18 to 64 years old (mean +/- SD = 34.5 +/- 13.7), The bladder cancer group consisted of 58 male and 13 female patients, ranging from 28 to 82 years old (mean +/- SD = 60.8 +/- 11.6), who were being treated at several hospitals. The slow phenotype, defined as an acetylation ratio (acetylisoniazid/isoniazid) of less than 2.0, was observed in 13 (14.3%) of the 91 healthy subjects, and in 20 (28.2%) of the 71 bladder cancer patients; the difference between the two groups is significant (P < 0.05), A histogram of the acetylation ratio values showed an overall leftward shift of the patient group, indicating low values of acetylation ratio in this group as a whole (P < 0.01),
引用
收藏
页码:1179 / 1181
页数:3
相关论文
共 18 条
[1]  
CARTWRIGHT RA, 1982, LANCET, V2, P842
[2]   THE ASSOCIATION OF THE SLOW ACETYLATOR PHENOTYPE WITH BLADDER-CANCER [J].
EVANS, DAP ;
EZE, LC ;
WHIBLEY, EJ .
JOURNAL OF MEDICAL GENETICS, 1983, 20 (05) :330-333
[3]  
EVANS DAP, 1960, BRIT MED J, V13, P485
[4]  
HAYASHI O, 1992, JPN J HYG, V47, P295
[5]   ACETYLTRANSFERASES AND SUSCEPTIBILITY TO CHEMICALS [J].
HEIN, DW ;
RUSTAN, TD ;
DOLL, MA ;
BUCHER, KD ;
FERGUSON, RJ ;
FENG, Y ;
FURMAN, EJ ;
GRAY, K .
TOXICOLOGY LETTERS, 1992, 64-5 :123-130
[6]  
HORAI Y, 1989, EUR J CLIN PHARMACOL, V37, P581
[7]   N-ACETYLATION POLYMORPHISM OF DAPSONE IN A JAPANESE POPULATION [J].
HORAI, Y ;
ISHIZAKI, T .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (04) :487-494
[8]  
KLARK DWJ, 1985, DRUGS, V29, P342
[9]  
LOWER GM, 1979, KENV HLTH PERSPECT, V20, P71
[10]   GENETIC POLYMORPHISMS OF DRUG-METABOLISM [J].
MEYER, UA .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1990, 4 (06) :595-615